<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/64BC5E73-972F-41E1-A12C-D97DC9BDFB93"><gtr:id>64BC5E73-972F-41E1-A12C-D97DC9BDFB93</gtr:id><gtr:name>MRC Clinical Sciences Centre</gtr:name><gtr:address><gtr:line1>Faculty of Medicine Imperial College</gtr:line1><gtr:line2>London Hammersmith Campus</gtr:line2><gtr:line3>Du Cane Road</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>W12 0NN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/64BC5E73-972F-41E1-A12C-D97DC9BDFB93"><gtr:id>64BC5E73-972F-41E1-A12C-D97DC9BDFB93</gtr:id><gtr:name>MRC Clinical Sciences Centre</gtr:name><gtr:address><gtr:line1>Faculty of Medicine Imperial College</gtr:line1><gtr:line2>London Hammersmith Campus</gtr:line2><gtr:line3>Du Cane Road</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>W12 0NN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9E2D9EFD-F7EE-46A4-BCEC-CB8419909C4A"><gtr:id>9E2D9EFD-F7EE-46A4-BCEC-CB8419909C4A</gtr:id><gtr:firstName>James</gtr:firstName><gtr:otherNames>Mitchell</gtr:otherNames><gtr:surname>Leiper</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U120097118"><gtr:id>3B5AC6D8-465B-4803-B61F-364A4DA89607</gtr:id><gtr:title>Nitric Oxide Signalling</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U120097118</gtr:grantReference><gtr:abstractText>Nitric oxide is an important regulator of blood vessel function that modulates vascular relaxation and thereby contributes to the maintenance of normal blood pressure. Reduction in vascular nitric oxide production causes cardiovascular diseases including hypertension, athero-sclerosis and heart failure in experimental animals. In patients with cardiovascular disease reduced nitric oxide production has been observed. We have identified a novel pathway that has the potential to regulate nitric oxide synthesis. Thus, naturally occurring modified forms of the amino acid arginine (ADMA) block nitric oxide synthesis. In this programme of work we plan to 1) Elucidate the role of ADMA in the regulation of cardiovascular function during health and disease, 2) Determine the role of the genes that regulate ADMA levels in the regulation of cardiovascular function in healthy humans and patients with cardiovascular disease, 3) Explore the therapeutic potential of altering the levels of ADMA in cardiovascular disease states, 4) Investigate the unexpected finding that ADMA plays a critical role during embryonic development. At the end of this programme we will have a clear understanding of role of ADMA in the regulation of cardiovascular function in humans and the potential to develop new medicines based upon manipulation of the concentration of these molecules.</gtr:abstractText><gtr:technicalSummary>Asymmetric dimethylarginine was first described by Vallance et al. in 1992 as an endogenous inhibitor of nitric oxide synthases (NOS) that accumulates in patients with renal failure. Since then plasma ADMA has been shown to predict cardiovascular events and overall mortality in patients with end stage renal failure, and plasma levels appear to be elevated in a wide range of human disease states including hypertension, atherosclerosis, preeclampsia and heart failure. In humans the major route of clearance of ADMA is metabolism catalysed by two isoforms of the enzyme dimethylarginine dimethylamino-hydrolase (DDAH). In experimental animals, genetic or pharmacological depletion of DDAH activity leads to increases in ADMA concentrations, inhibition of cardiovascular nitric oxide (NO) generation and hypertension. These data suggest that DDAH, acting via ADMA, is a significant regulator of NO production in vivo and suggest that genetic or environmental factors that modulate DDAH activity in humans might have a significant impact on cardiovascular function and disease progression. This programme is focussed on ADMA and its metabolic pathways across a range of cardiovascular physiology and pathophysiology.|Endogenously produced ADMA can exert significant effects on cardiovascular function under normal physiological conditions and that DDAH is an important regulator of ADMA levels in vivo. However, whilst global over expression/ deletion of DDAH genes and inhibition of DDAH activity in experimental animals have provided the first evidence for a causal role for the DDAH/ADMA pathway in the regulation of cardiovascular nitric oxide signalling our understanding of the mechanisms that dynamically regulate DDAH expression and the identity of key cardiovascular cell types in which DDAH and ADMA exert significant effects during both physiological and pathophysiological situations remains limited. Moreover it is unclear how the observations from experimental animals translate to the situation in man. Finally, a deeper understanding of the functions of DDAH may provide novel therapeutic opportunities, particularly where excessive nitric oxide production contributes to pathology.|We have generated reagents and a depth of expertise in this field that is recognised as unique. Resources include DDAH1 and 2 global, conditional and inducible knockout and transgenic mice, potent inhibitors of DDAH, DDAH crystal structures and identified single nucleotide polymorphisms in human DDAH genes that modulate expression levels. In this programme of work we plan to utilise these reagents and expertise to understand 1) the mechanisms of action of DDAH and ADMA in the regulation of cardiovascular function in health and disease 2) the contribution of genetic variation in DDAH to the progression of disease in human populations 3) the therapeutic potential of small molecule modulators of DDAH activity and 4) role of DDAH1 during embryonic development. This programme is wide ranging spanning the fields of molecular, structural and chemical biology, cardiovascular physiology, human genetics and developmental biology. Research in our group is currently funded by a BHF programme grant, a Wellcome Trust translational award and a European Commission FP6 award. The additional resources requested from the MRC will allow us to develop a fully integrated programme with the potential to translate our basic research findings into new therapeutics for the treatment of human disease.</gtr:technicalSummary><gtr:fund><gtr:end>2018-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-05-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>6932502</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>BHF Studentship</gtr:description><gtr:id>961AF650-2A34-404D-9F09-0733FAFEF172</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>LmcWb7ocugk-1</gtr:outcomeId><gtr:partnerContribution>Co-applicants on grant</gtr:partnerContribution><gtr:piContribution>Co-applicants on grant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>BHF Project Grant</gtr:description><gtr:id>ABDFB332-59FE-4555-B781-004041006078</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>YPE2AczuHSo-1</gtr:outcomeId><gtr:partnerContribution>Co-applicant and grant</gtr:partnerContribution><gtr:piContribution>Co applicants</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Organiser of The Heart and Circulation Course</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>65AA0E7E-1C2E-4280-A449-2B26C37AAFD0</gtr:id><gtr:impact>Organiser of the third year module for non-clinical and clinical undergraduates. (University College London PHOL 3002. 2006-2009)

n/a</gtr:impact><gtr:outcomeId>n3v1JM2hut6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecturer on Molecular Medicine MSc Course</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1D1E9242-DD90-4E41-B2D7-05EF19547C15</gtr:id><gtr:impact>Imperial College London, 2009 to date

n/a</gtr:impact><gtr:outcomeId>Vw6cE9NiRXe</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>3rd International Symposium on ADMA Research, London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F68D8A1B-861A-4BF9-96C5-1A86DB5DE35F</gtr:id><gtr:impact>Member of the organising committee

n/a</gtr:impact><gtr:outcomeId>BwiaE3bU5vu</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecturer on Drug Design and Development Course</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7E1D70F6-1653-4E75-AFBA-A0F9E186AB54</gtr:id><gtr:impact>Lecturer at UCL, PHAR3006. 2002 to date.

n/a</gtr:impact><gtr:outcomeId>cuEj2GkVsfx</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>Pre-2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>World Congress of Nephrology, Kyoto, Japan</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4EB917E0-E1BF-43F4-AA11-DA7E5611876E</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>Da6bqCYFWAx</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>4th International Symposium on ADMA Research, Bregenz, Austria</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4583B5E7-BA42-4FD9-9145-7263B9F6D806</gtr:id><gtr:impact>Member of the organising committee

n/a</gtr:impact><gtr:outcomeId>KM2LT1aMy8A</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>LifeSciences, Glasgow</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1C308668-3693-4A14-842B-BEA367CA7C7D</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>Jzpfe8N95yo</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MDC/CSC Retreat</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>09ADE676-0DAD-4D17-BA8D-5428B90449CF</gtr:id><gtr:impact>Presented 20 minute talk followed by 10 minute discussion.

N/A</gtr:impact><gtr:outcomeId>gxGnTC9Fpr4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>5th International Symposium on ADMA, Chicago, USA</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F8CA475D-00DF-48D6-9169-F2269FC8F752</gtr:id><gtr:impact>Member of the organising committee

n/a</gtr:impact><gtr:outcomeId>ESDY8hxgJZN</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Japanese Renal Association Meeting, Shizoka, Japan</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>83F57F93-E3E5-44D3-936C-308B4F378AD6</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>gUfJUdzKyMD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>World Conference of Nephrology, Milan, Italy</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D811BDBC-8574-4CDD-AF8F-AE2B40A72175</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>Em6ARRedeuM</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Frontiers in Vascular Medicine, Melbourne, Australia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EC8FE55C-FDD0-4654-B564-6490213E39F4</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>tRCcch3AYhe</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>3rd International Workshop on Cardiovascular Biology, London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>05DB524A-C3C9-4F9F-8F22-44F495DF99C2</gtr:id><gtr:impact>Member of the organising committee.

n/a</gtr:impact><gtr:outcomeId>roYRj9gooGU</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Inflammation Research Association Meeting: 25 Years of Nitric Oxide Research, Boston, US</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BBF35197-8926-4B7F-980F-632A63CBCFB5</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>gPaHtAdqxVE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>Pre-2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Annual World Congress on the Insulin Resistance Syndrome</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BA48712D-F2D6-4EF9-8339-29173916A8F7</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>LD7ndrXTJgQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>6th International Symposium on ADMA Research, London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E90CB8E2-6163-4CD6-9E66-F4B887EDB862</gtr:id><gtr:impact>Member of the organising committee

n/a</gtr:impact><gtr:outcomeId>tE318R4kPC4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>183010</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Heart Foundation Project Grant</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>8B82BD8E-296B-4735-9C3E-963D6D954FC5</gtr:id><gtr:outcomeId>ScGtrseeAQ6</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>236395</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant</gtr:description><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>C2997852-180C-4F89-B824-16E073FD01CA</gtr:id><gtr:outcomeId>gdR41jc64RZ0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>108000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Technology Development Gap.Fund.</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>6BE81F9E-0F56-40CC-AAC9-3DD8C34507CE</gtr:id><gtr:outcomeId>RZLMTw3xLST</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>European Commission FP6 Network of Exellence</gtr:description><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>83C5BAC1-0A6C-4709-AC50-2A5112F749CC</gtr:id><gtr:outcomeId>d4eFmeyRKY50</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1302907</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Programme Grant</gtr:description><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>511F7ABC-3491-47A2-B403-6B9452ED9738</gtr:id><gtr:outcomeId>ANMpgjRVFQ90</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2800000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Intramural Research Programme Funding</gtr:description><gtr:end>2014-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>C57202E4-D20A-4439-82AD-3911702A9837</gtr:id><gtr:outcomeId>TNCFS6DKDeZ</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>285000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>European Commission FP6</gtr:description><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>B00A11F7-E02B-4F03-8213-C0FF32E35BC8</gtr:id><gtr:outcomeId>Z31ZXfLuGGv0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>358750</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Equipment Grant</gtr:description><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>38434AA9-EEB9-4959-90EF-71D3CC9EE553</gtr:id><gtr:outcomeId>n2FNyjVPHpC0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>94114</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Project Grant</gtr:description><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>7D1BE201-396E-47B2-A5E1-0A34466FD7F3</gtr:id><gtr:outcomeId>pTnyseFdN5B0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>254086</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Heart Foundation Project Grant</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>935E182E-94DE-407E-8A91-8B512B4811C3</gtr:id><gtr:outcomeId>M36EdKt3Kk5</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Seeding Drug Discover Initiative</gtr:description><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>74BC291B-2A83-469E-B56B-CD751803F6C4</gtr:id><gtr:outcomeId>BT6SaNnw4Uu0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>760000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ESRC Platform Grant</gtr:description><gtr:fundingOrg>Economic and Social Research Council</gtr:fundingOrg><gtr:id>C64A64C8-1555-4EA5-B025-BAF081F4AAA9</gtr:id><gtr:outcomeId>k3VTzqDbkAq0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75300</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF PhD Studentship</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>5E5EBA99-DADA-43B5-9204-F980F4303417</gtr:id><gtr:outcomeId>WXPm7oKQMbZ</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>85000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF PhD Studentship</gtr:description><gtr:end>2014-04-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>4595DE4F-0800-4AFE-95DC-7C1077E33FC6</gtr:id><gtr:outcomeId>LqgpamXytqZ0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Assay for measuring asymetric methylarginine in a biological sample</gtr:description><gtr:grantRef>MC_U120097118</gtr:grantRef><gtr:id>0B05BABF-9781-40D9-B6C6-00FCA04F5BAE</gtr:id><gtr:impact>n/a</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>ET65X4KBYrk</gtr:outcomeId><gtr:patentId>US2009053741</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Assay for measuring asymetric methylarginine in a biological sample</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Assay for measuring asymetric methylarginine in a biological sample</gtr:description><gtr:grantRef>MC_U120097118</gtr:grantRef><gtr:id>DFD915A5-15EF-48D1-849C-ACDEA4BBD9A2</gtr:id><gtr:impact>n/a</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>BZGs1uZzwRh</gtr:outcomeId><gtr:patentId>US2009053741</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Assay for measuring asymetric methylarginine in a biological sample</gtr:title><gtr:yearProtectionGranted>2006</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Guanidine derivatives as inhibitors of DDAH</gtr:description><gtr:grantRef>MC_U120097118</gtr:grantRef><gtr:id>49148829-518E-4EE7-94B7-601F77279FB7</gtr:id><gtr:impact>n/a</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>PCv3L4Fyq82</gtr:outcomeId><gtr:patentId>US20050719208</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Guanidine derivatives as inhibitors of DDAH</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Screen Method</gtr:description><gtr:grantRef>MC_U120097118</gtr:grantRef><gtr:id>42D6FE4E-2D04-4554-B174-3BB9B16E787C</gtr:id><gtr:impact>n/a</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>ddwM4YAzvpf</gtr:outcomeId><gtr:patentId>WO0044888</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Screen Method</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Dimethylarginine Dimethylaminohydrolases</gtr:description><gtr:grantRef>MC_U120097118</gtr:grantRef><gtr:id>110E8D2E-9619-487A-A779-A897EDCA80E5</gtr:id><gtr:impact>n/a</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>mtWTM4areLa</gtr:outcomeId><gtr:patentId>US20040966039</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Dimethylarginine Dimethylaminohydrolases</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>40914AF3-D6A2-4DF3-A5E9-D59DF18723F2</gtr:id><gtr:title>The ADMA/DDAH pathway is a critical regulator of endothelial cell motility.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4478e3ff9c0cddbb8611f97dab6ed235"><gtr:id>4478e3ff9c0cddbb8611f97dab6ed235</gtr:id><gtr:otherNames>Wojciak-Stothard B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>NqkmSjAs6aH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A91039ED-B68C-4A5C-89AE-CB4A0613A264</gtr:id><gtr:title>NRF2 PREVENTS HYPERTENSION, INCREASED ADMA, MICROVASCULAR OXIDATIVE STRESS AND DYSFUNCTION IN MICE WITH TWO WEEKS OF ANGIOTENSIN II INFUSION.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Regulatory, integrative and comparative physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55e9c812cfbba94f1e7e00b693cdb8e1"><gtr:id>55e9c812cfbba94f1e7e00b693cdb8e1</gtr:id><gtr:otherNames>Wang C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0363-6119</gtr:issn><gtr:outcomeId>5a9d59e33a9523.79529572</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8F6ADBE-3FA7-4707-90DE-8972B35055A3</gtr:id><gtr:title>Role of asymmetric methylarginine and connexin 43 in the regulation of pulmonary endothelial function.</gtr:title><gtr:parentPublicationTitle>Pulmonary circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04dd730e188dc6c2f97126bb6ef1bf20"><gtr:id>04dd730e188dc6c2f97126bb6ef1bf20</gtr:id><gtr:otherNames>Tsang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2045-8932</gtr:issn><gtr:outcomeId>5460ad0f2e9dd3.15302802</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4098EBA0-5B30-405F-BD2C-1CD18B1C21D8</gtr:id><gtr:title>miR-21/DDAH1 pathway regulates pulmonary vascular responses to hypoxia.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91f8dfc2c73813990eefd09dae4f1f03"><gtr:id>91f8dfc2c73813990eefd09dae4f1f03</gtr:id><gtr:otherNames>Iannone L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>5460ad0eb75b61.08633183</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE52238F-4C1D-4C2E-8FB0-F67E0FD7F997</gtr:id><gtr:title>Endothelial Dimethylarginine Dimethylaminohydrolase 1 Is an Important Regulator of Angiogenesis but Does Not Regulate Vascular Reactivity or Hemodynamic Homeostasis.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61bfd7489b07c162688dc18814441c19"><gtr:id>61bfd7489b07c162688dc18814441c19</gtr:id><gtr:otherNames>Dowsett L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>56b9e4fdef8c73.02274581</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD1BD549-35B2-445A-A050-C16B922C8746</gtr:id><gtr:title>Adenoviral-mediated overexpression of DDAH improves vascular tone regulation.</gtr:title><gtr:parentPublicationTitle>Vascular medicine (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8703ad164021168fbb518a8586736317"><gtr:id>8703ad164021168fbb518a8586736317</gtr:id><gtr:otherNames>Torondel B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1358-863X</gtr:issn><gtr:outcomeId>C7K6DB7hQoi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0EDE469-520B-4DD7-89D2-3DC4D4E2EE82</gtr:id><gtr:title>New tricks from an old dog: nitric oxide-independent effects of dimethylarginine dimethylaminohydrolase.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d45826f73744a72402c74eea3d5f50e6"><gtr:id>d45826f73744a72402c74eea3d5f50e6</gtr:id><gtr:otherNames>Leiper J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn><gtr:outcomeId>pm_15611_11_16794231</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FD245CA-D778-4046-81C0-6C433ADFE3F7</gtr:id><gtr:title>Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d401b9069e3f149e856ee361dc533fdc"><gtr:id>d401b9069e3f149e856ee361dc533fdc</gtr:id><gtr:otherNames>Mookerjee RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>h2bri6NqCwb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB924A73-BA89-49C9-B6DB-6E6913FC8A5B</gtr:id><gtr:title>Dimethylarginine dimethylaminohydrolase 2 regulates nitric oxide synthesis and hemodynamics and determines outcome in polymicrobial sepsis.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64d910e07fe70473f6989d400009e3b6"><gtr:id>64d910e07fe70473f6989d400009e3b6</gtr:id><gtr:otherNames>Lambden S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn><gtr:outcomeId>56b9e4fe345c17.17466617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3977BE4-76FD-498F-801E-98C38EF56136</gtr:id><gtr:title>Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/058a95503988c4d3230f1706a0fdf676"><gtr:id>058a95503988c4d3230f1706a0fdf676</gtr:id><gtr:otherNames>Boult JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>pm_15611_21_21590769</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9547D33-24E0-45F1-9922-EBD85FC9F58D</gtr:id><gtr:title>Overexpression of GTP cyclohydrolase 1 feedback regulatory protein is protective in a murine model of septic shock.</gtr:title><gtr:parentPublicationTitle>Shock (Augusta, Ga.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41c7ef2197cebce610c6b69fe5ed99b8"><gtr:id>41c7ef2197cebce610c6b69fe5ed99b8</gtr:id><gtr:otherNames>Starr A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1073-2322</gtr:issn><gtr:outcomeId>5460ad0e89b809.80687537</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5408E852-ED55-4C2E-B34F-993F3B2A86B3</gtr:id><gtr:title>The role of ATM in response to metformin treatment and activation of AMPK.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f21038a541b4c1a706eba12796d5349"><gtr:id>8f21038a541b4c1a706eba12796d5349</gtr:id><gtr:otherNames>Woods A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_15611_21_22456733</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C9EFB1C-7CF4-4345-906C-B033D2E619D9</gtr:id><gtr:title>The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Drug discovery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d45826f73744a72402c74eea3d5f50e6"><gtr:id>d45826f73744a72402c74eea3d5f50e6</gtr:id><gtr:otherNames>Leiper J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1474-1776</gtr:issn><gtr:outcomeId>rdMuPe4VVt9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CE5D862-8C89-4423-BB5F-F740E62F5936</gtr:id><gtr:title>Immunolocalisation and activity of DDAH I and II in the heart and modification post-myocardial infarction.</gtr:title><gtr:parentPublicationTitle>Acta histochemica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af020d126456d05e975c5e00c444d0ae"><gtr:id>af020d126456d05e975c5e00c444d0ae</gtr:id><gtr:otherNames>Gray GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0065-1281</gtr:issn><gtr:outcomeId>thdc8QPogmZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C12F7E2-C676-48EE-A4DA-B670770681C3</gtr:id><gtr:title>Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis.</gtr:title><gtr:parentPublicationTitle>Experimental eye research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5149d219d7240db05041302902c6636"><gtr:id>b5149d219d7240db05041302902c6636</gtr:id><gtr:otherNames>Lange C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0014-4835</gtr:issn><gtr:outcomeId>5a9d59e3e7fff5.55895770</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BDD7529-AADC-44EF-8EC8-8D9D632BCDC7</gtr:id><gtr:title>Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fcf0fc2258bb9a4fffc95a9e89defdc7"><gtr:id>fcf0fc2258bb9a4fffc95a9e89defdc7</gtr:id><gtr:otherNames>Caplin B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn><gtr:outcomeId>pm_15611_21_22460557</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BA032D2-EACD-42CC-A292-7A161C84B1E6</gtr:id><gtr:title>Alanine-glyoxylate aminotransferase-2 metabolizes endogenous methylarginines, regulates NO, and controls blood pressure.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fcf0fc2258bb9a4fffc95a9e89defdc7"><gtr:id>fcf0fc2258bb9a4fffc95a9e89defdc7</gtr:id><gtr:otherNames>Caplin B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn><gtr:outcomeId>pm_15611_21_23023372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D435BBDA-AEE5-403A-BE95-C783514C748A</gtr:id><gtr:title>Selective substrate-based inhibitors of mammalian dimethylarginine dimethylaminohydrolase.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1aec323a293ed17794f9ce7e3c3a27f"><gtr:id>d1aec323a293ed17794f9ce7e3c3a27f</gtr:id><gtr:otherNames>Rossiter S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>NpRvbrb9hwD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD56BEFD-CB61-4655-847C-A667FA9D88B8</gtr:id><gtr:title>Expression of NG,NG-dimethylarginine dimethylaminohydrolase and protein arginine N-methyltransferase isoforms in diabetic rat kidney: effects of angiotensin II receptor blockers.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/378906bda6ddabff1d8112ce34e51d71"><gtr:id>378906bda6ddabff1d8112ce34e51d71</gtr:id><gtr:otherNames>Onozato ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>XDwfHhwwpRw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FEE378C-472F-442D-B732-FA000F8F9239</gtr:id><gtr:title>Reply to letter regarding article, &amp;quot;evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0e9e4916782b9cb2c34211fa85ac948"><gtr:id>b0e9e4916782b9cb2c34211fa85ac948</gtr:id><gtr:otherNames>Ahmetaj-Shala B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>56b9e4fc9125f4.39864641</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>738408E0-0715-4947-A29F-4E46C9F7507C</gtr:id><gtr:title>A role for Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) in mammalian development.</gtr:title><gtr:parentPublicationTitle>The International journal of developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/daf342954ef6f15c10706d127234ee8b"><gtr:id>daf342954ef6f15c10706d127234ee8b</gtr:id><gtr:otherNames>Breckenridge RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0214-6282</gtr:issn><gtr:outcomeId>SR9fauj1bQx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1598686-1388-4285-B757-59885762E1C5</gtr:id><gtr:title>Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d4abefe8b50cd360610b80cdf07d3f6"><gtr:id>9d4abefe8b50cd360610b80cdf07d3f6</gtr:id><gtr:otherNames>Libri V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>5460ad0edcc9e1.81984950</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9E9841D-6B81-4FD3-91CA-76877993FFB6</gtr:id><gtr:title>The ADMA/DDAH pathway regulates VEGF-mediated angiogenesis.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32e3695f6a0affde99ac87de83a43464"><gtr:id>32e3695f6a0affde99ac87de83a43464</gtr:id><gtr:otherNames>Fiedler LR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn><gtr:outcomeId>rKUfmH6W9Ga</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58BD8099-6696-4036-AE7D-ED0F72826540</gtr:id><gtr:title>Disruption of methylarginine metabolism impairs vascular homeostasis.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d45826f73744a72402c74eea3d5f50e6"><gtr:id>d45826f73744a72402c74eea3d5f50e6</gtr:id><gtr:otherNames>Leiper J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>Hh1mP1dcUo2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1871B808-F819-42B0-8562-A049921C4A58</gtr:id><gtr:title>Developmental regulation of GTP-CH1 in the porcine lung and its relationship to pulmonary vascular relaxation.</gtr:title><gtr:parentPublicationTitle>Pediatric research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b509174458d294ad37adfbcfed56936"><gtr:id>6b509174458d294ad37adfbcfed56936</gtr:id><gtr:otherNames>Nandi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0031-3998</gtr:issn><gtr:outcomeId>hFuz4fTt7wE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B29C9D9A-76E9-4F17-887F-A9D17312E821</gtr:id><gtr:title>Isoform-specific regulation by N(G),N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0385ddf822030de0fee889762bbc89e"><gtr:id>a0385ddf822030de0fee889762bbc89e</gtr:id><gtr:otherNames>Wang D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn><gtr:outcomeId>F4zWhZMH4W1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C350764A-7A7B-4FCA-9EDA-2763820FB430</gtr:id><gtr:title>Discovery of inhibitors of the pentein superfamily protein dimethylarginine dimethylaminohydrolase (DDAH), by virtual screening and hit analysis.</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92b6d27d987a3c6fbaf6232402ec90a6"><gtr:id>92b6d27d987a3c6fbaf6232402ec90a6</gtr:id><gtr:otherNames>Hartzoulakis B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0960-894X</gtr:issn><gtr:outcomeId>KnHoqszpx4e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>594A78F1-F3AC-4579-BB14-3DAE361F43D7</gtr:id><gtr:title>A Novel Pathway for Metabolism of the Cardiovascular Risk Factor Homoarginine by alanine:glyoxylate aminotransferase 2.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c53d557511f137e2e151d596ca9adb0f"><gtr:id>c53d557511f137e2e151d596ca9adb0f</gtr:id><gtr:otherNames>Rodionov RN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a9d59e3b34103.37174172</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>396EF1C1-9EF0-4BFF-9489-DD568825AD8D</gtr:id><gtr:title>Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0e9e4916782b9cb2c34211fa85ac948"><gtr:id>b0e9e4916782b9cb2c34211fa85ac948</gtr:id><gtr:otherNames>Ahmetaj-Shala B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>56b9e4feb324b4.02551264</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAA2303A-0F17-49A7-9962-B7BB829B135A</gtr:id><gtr:title>The response of the innate immune and cardiovascular systems to LPS in pregnant and nonpregnant mice.</gtr:title><gtr:parentPublicationTitle>Biology of reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04061cc8515d9b4ffa05df81b9022cf0"><gtr:id>04061cc8515d9b4ffa05df81b9022cf0</gtr:id><gtr:otherNames>Z?llner J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-3363</gtr:issn><gtr:outcomeId>5a9d59e36be273.38360153</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50B63B5A-A9D9-4951-BFFD-B494251A2985</gtr:id><gtr:title>Pharmacological inhibition of DDAH1 improves survival, haemodynamics and organ function in experimental septic shock.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/904f884f2cedac3bc8311c15aeb35f7b"><gtr:id>904f884f2cedac3bc8311c15aeb35f7b</gtr:id><gtr:otherNames>Wang Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>5460ad0f551e27.85149922</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF400A53-2EFF-42B0-ADB1-FB99EBE643FB</gtr:id><gtr:title>Circulating methylarginine levels and the decline in renal function in patients with chronic kidney disease are modulated by DDAH1 polymorphisms.</gtr:title><gtr:parentPublicationTitle>Kidney international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fcf0fc2258bb9a4fffc95a9e89defdc7"><gtr:id>fcf0fc2258bb9a4fffc95a9e89defdc7</gtr:id><gtr:otherNames>Caplin B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0085-2538</gtr:issn><gtr:outcomeId>a3GHcUAqnWN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C35EFDC-169A-4796-A7CF-4DE819531ED5</gtr:id><gtr:title>Analysis of methylarginine metabolism in the cardiovascular system identifies the lung as a major source of ADMA.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Lung cellular and molecular physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f875853eda2b60fbf51ddcb5cc92ab48"><gtr:id>f875853eda2b60fbf51ddcb5cc92ab48</gtr:id><gtr:otherNames>Bulau P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1040-0605</gtr:issn><gtr:outcomeId>F3BXdxZY5Rk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DABB8064-D789-4A99-B2D3-F3E2BDAFB787</gtr:id><gtr:title>The DDAH-ADMA-NOS pathway.</gtr:title><gtr:parentPublicationTitle>Therapeutic drug monitoring</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30bc8a35ca95a794fc8b93c1d36af683"><gtr:id>30bc8a35ca95a794fc8b93c1d36af683</gtr:id><gtr:otherNames>Leiper JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0163-4356</gtr:issn><gtr:outcomeId>pm_15611_11_16404814</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43927000-8975-4C3C-92C1-620443F2DB6E</gtr:id><gtr:title>C-terminus of heat shock protein 70-interacting protein-dependent GTP cyclohydrolase I degradation in lambs with increased pulmonary blood flow.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/472da9529c9f003ed033d63c908c5297"><gtr:id>472da9529c9f003ed033d63c908c5297</gtr:id><gtr:otherNames>Sun X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1044-1549</gtr:issn><gtr:outcomeId>JJ2vhD1iPBP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C47C34D-8645-4FA6-9C3E-1B7C7B7C049F</gtr:id><gtr:title>Effects of ADMA upon gene expression: an insight into the pathophysiological significance of raised plasma ADMA.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7a2eaed345ae795011f7075771aae4e"><gtr:id>e7a2eaed345ae795011f7075771aae4e</gtr:id><gtr:otherNames>Smith CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>ffP5a7JBrP3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A7285B4-A4FF-47B9-889E-F8120E4A4B7F</gtr:id><gtr:title>cAMP phosphodiesterase inhibitors increases nitric oxide production by modulating dimethylarginine dimethylaminohydrolases.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec37b4aa35f01570b4d17b30d0e78a5e"><gtr:id>ec37b4aa35f01570b4d17b30d0e78a5e</gtr:id><gtr:otherNames>Pullamsetti SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>FRhLfbmnWgt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5A098D0-140F-45C9-A1D4-5B1B9B91FD25</gtr:id><gtr:title>Metabolomic profiling of amines in sepsis predicts changes in NOS canonical pathways.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2428dd40b954d5ee0a54477146869bf"><gtr:id>d2428dd40b954d5ee0a54477146869bf</gtr:id><gtr:otherNames>Tesfai A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a9d59e3922ca0.25680689</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82D6965F-B017-4928-963D-1A2141F98C48</gtr:id><gtr:title>Dimethylarginine dimethylaminohydrolase 1 is involved in spinal nociceptive plasticity.</gtr:title><gtr:parentPublicationTitle>Pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85de5bc61bef36fdc86b246f477d2b94"><gtr:id>85de5bc61bef36fdc86b246f477d2b94</gtr:id><gtr:otherNames>D'Mello R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0304-3959</gtr:issn><gtr:outcomeId>56b9e4fdbeb412.86309523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BE16CE8-0274-486E-AE16-423EBB33CBD4</gtr:id><gtr:title>Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9fdd628e72feba3877bc4f3745fd824"><gtr:id>e9fdd628e72feba3877bc4f3745fd824</gtr:id><gtr:otherNames>Ghebremariam YT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>pm_15611_21_23825361</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79E108B8-4653-4E48-A53C-2A2C864B85B2</gtr:id><gtr:title>Response to letters regarding article, &amp;quot;unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9fdd628e72feba3877bc4f3745fd824"><gtr:id>e9fdd628e72feba3877bc4f3745fd824</gtr:id><gtr:otherNames>Ghebremariam YT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>5460ad0f0c6af5.77125487</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EE2749D-7841-4285-A684-B77237019EEA</gtr:id><gtr:title>Over-expression of GTP-cyclohydrolase 1 feedback regulatory protein attenuates LPS and cytokine-stimulated nitric oxide production.</gtr:title><gtr:parentPublicationTitle>Vascular medicine (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b509174458d294ad37adfbcfed56936"><gtr:id>6b509174458d294ad37adfbcfed56936</gtr:id><gtr:otherNames>Nandi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1358-863X</gtr:issn><gtr:outcomeId>pm_15611_11_18372436</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39AD767C-CAE4-43F3-9079-1F9FD54CE4DF</gtr:id><gtr:title>Genetic and pharmacological inhibition of dimethylarginine dimethylaminohydrolase 1 is protective in endotoxic shock.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b509174458d294ad37adfbcfed56936"><gtr:id>6b509174458d294ad37adfbcfed56936</gtr:id><gtr:otherNames>Nandi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn><gtr:outcomeId>pm_15611_21_22995517</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E97F00BE-47A7-4707-83C2-6A7E91333F1A</gtr:id><gtr:title>Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and -2.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Heart and circulatory physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa424d41c1beac11cbeba84c5ab5272f"><gtr:id>fa424d41c1beac11cbeba84c5ab5272f</gtr:id><gtr:otherNames>Ivashchenko CY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0363-6135</gtr:issn><gtr:outcomeId>pm_15611_11_19915177</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BD23184-4916-4118-8A76-786F9793C49F</gtr:id><gtr:title>Rho GTPases and hypoxia in pulmonary vascular endothelial cells.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4478e3ff9c0cddbb8611f97dab6ed235"><gtr:id>4478e3ff9c0cddbb8611f97dab6ed235</gtr:id><gtr:otherNames>Wojciak-Stothard B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0076-6879</gtr:issn><gtr:outcomeId>pm_15611_11_18374171</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4607DDA8-C8DA-402D-AD26-6DAB8524B5EA</gtr:id><gtr:title>The role of dimethylarginine dimethylaminohydrolase in idiopathic pulmonary fibrosis.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec37b4aa35f01570b4d17b30d0e78a5e"><gtr:id>ec37b4aa35f01570b4d17b30d0e78a5e</gtr:id><gtr:otherNames>Pullamsetti SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>VhSEi1t4SwA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B67C282B-5E78-4769-9B6D-F0E442056EE1</gtr:id><gtr:title>Symmetric dimethylarginine (SDMA) is raised in women with polycystic ovary syndrome: a pilot study.</gtr:title><gtr:parentPublicationTitle>Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7ae86949732266e85087ff4cff68511"><gtr:id>e7ae86949732266e85087ff4cff68511</gtr:id><gtr:otherNames>Lakhani K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0144-3615</gtr:issn><gtr:outcomeId>fxt4wjLhKzH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0A93421-0C95-4E58-B740-F05F7631A952</gtr:id><gtr:title>Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney Damage.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/904b9fe32d176b63910f4998829daf78"><gtr:id>904b9fe32d176b63910f4998829daf78</gtr:id><gtr:otherNames>Tomlinson JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn><gtr:outcomeId>56b9e6cbce0af5.21854709</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E8187C8-E58D-43D4-BB6C-16770E163971</gtr:id><gtr:title>Modulation of Rac1 activity by ADMA/DDAH regulates pulmonary endothelial barrier function.</gtr:title><gtr:parentPublicationTitle>Molecular biology of the cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4478e3ff9c0cddbb8611f97dab6ed235"><gtr:id>4478e3ff9c0cddbb8611f97dab6ed235</gtr:id><gtr:otherNames>Wojciak-Stothard B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1059-1524</gtr:issn><gtr:outcomeId>gamzkKJxUaE</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U120097118</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>